[go: up one dir, main page]

AU2002212395A1 - Method and preparation for binding acetaldehyde in saliva, stomach and large intestine - Google Patents

Method and preparation for binding acetaldehyde in saliva, stomach and large intestine

Info

Publication number
AU2002212395A1
AU2002212395A1 AU2002212395A AU1239502A AU2002212395A1 AU 2002212395 A1 AU2002212395 A1 AU 2002212395A1 AU 2002212395 A AU2002212395 A AU 2002212395A AU 1239502 A AU1239502 A AU 1239502A AU 2002212395 A1 AU2002212395 A1 AU 2002212395A1
Authority
AU
Australia
Prior art keywords
saliva
stomach
large intestine
preparation
binding acetaldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212395A
Inventor
Martti Marvola
Mikko Salaspuro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Licentia Oy
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Publication of AU2002212395A1 publication Critical patent/AU2002212395A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The object of the invention is the use of compounds comprising one or more free sulphlydryl or amino groups for preparing a pharmaceutical composition for locally binding acetaldehyde in saliva, the stomach or the large intestine, and pharmaceutical compositions comprising the said compounds.
AU2002212395A 2000-10-30 2001-10-30 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine Abandoned AU2002212395A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20002392 2000-10-30
FI20002392A FI121528B (en) 2000-10-30 2000-10-30 A pharmaceutical composition for reducing the risk of cancer by topically binding acetaldehyde in saliva, stomach or colon
PCT/FI2001/000948 WO2002036098A1 (en) 2000-10-30 2001-10-30 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine

Publications (1)

Publication Number Publication Date
AU2002212395A1 true AU2002212395A1 (en) 2002-05-15

Family

ID=8559405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212395A Abandoned AU2002212395A1 (en) 2000-10-30 2001-10-30 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine

Country Status (10)

Country Link
US (1) US9474733B2 (en)
EP (1) EP1339394B1 (en)
JP (1) JP4691312B2 (en)
CN (1) CN100467016C (en)
AT (1) ATE522203T1 (en)
AU (1) AU2002212395A1 (en)
EA (1) EA009335B1 (en)
ES (1) ES2370811T3 (en)
FI (1) FI121528B (en)
WO (1) WO2002036098A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI121528B (en) 2000-10-30 2010-12-31 Biohit Oyj A pharmaceutical composition for reducing the risk of cancer by topically binding acetaldehyde in saliva, stomach or colon
MXPA03004546A (en) 2000-11-22 2003-09-10 Rxkinetix Inc Treatment of mucositis.
JP5654726B2 (en) * 2004-10-08 2015-01-14 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ Methods and formulations for binding aldehydes in saliva
ITME20040015A1 (en) * 2004-12-07 2005-03-07 Vincenzo Savica CHEWING GUM, RUBBER CANDIES, TABLETS, SLOW TABLETS OF CHELANTI PHOSPHATE AND / OR PHOSPHORUS SALIVAR AND CAPSULES WITH SLOW RELEASE OF CHELANTS PHOSPHATE AND / OR PHOSPHORUS AT GASTROENTERIC LEVEL.
FI122914B (en) * 2005-04-01 2012-08-31 Biohit Oyj Food composition for binding of acetaldehyde in the mouth and in the digestive tract and process for the preparation of the composition
CA2615319A1 (en) * 2005-07-13 2007-01-18 Al Czap Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof
WO2007064755A2 (en) 2005-11-30 2007-06-07 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
FI20060501L (en) * 2006-05-22 2007-11-23 Biohit Oyj Composition and method for binding acetaldehyde in the stomach
US20100166833A1 (en) * 2007-05-07 2010-07-01 Technion Research & Development Foundation Ltd. Compositions, articles and methods for preventing or reducing tobacco-associated damage
FI120526B (en) * 2007-05-16 2009-11-30 Biohit Oyj Filter for tobacco product
FI20070705L (en) * 2007-09-14 2009-06-02 Biohit Oyj Binding of acetaldehyde in the mouth and in the stomach
US20090092664A1 (en) * 2007-10-08 2009-04-09 University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
IL188681A0 (en) 2008-01-09 2008-12-29 Amino Acid Solutions Inc Pharmaceutical compositions and methods utilizing a d-amino acid
FI20115680L (en) * 2011-06-29 2012-12-30 Biohit Oyj Liquid pharmaceutical compositions or combination products
FI129157B (en) * 2012-05-28 2021-08-13 Biohit Oyj Composition to reduce the incidence of or prevent severe headache
FI20135097A7 (en) * 2013-02-01 2014-08-02 Biohit Oyj Composition for binding aldehydes in the mouth
CA2905187A1 (en) 2013-03-12 2014-09-18 Biohit Oyj Encapsulated composition for binding aldehydes in the stomach
WO2014140410A1 (en) 2013-03-12 2014-09-18 Biohit Oyj Composition for oral administration for binding aldehydes in the gastrointestinal tract
FI20145217A7 (en) 2014-03-06 2015-09-07 Biohit Oyj Composition for binding aldehydes and free radicals in the gastrointestinal tract
CN108671232A (en) * 2018-07-09 2018-10-19 珠海中科先进技术研究院有限公司 A kind of combination preparation that can reduce internal acetaldehyde concentration and preparation method thereof and purposes
WO2020187712A1 (en) 2019-03-15 2020-09-24 Novo Nordisk A/S Process for spray drying a glp-1 peptide
US11717554B2 (en) * 2019-09-19 2023-08-08 Max R&D Llc Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)
CN119214993A (en) * 2024-09-27 2024-12-31 国家纳米科学中心 Hyaluronic acid nanogel for removing aldehyde groups, preparation method and application thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0054795B1 (en) * 1980-12-09 1987-07-15 Teijin Limited Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof
US4496548A (en) 1983-02-04 1985-01-29 Moldowan Mervin J Composition and method for reducing hangover
GB8313044D0 (en) 1983-05-12 1983-06-15 Caseley J R Reducing toxic effects of tobacco
US4528295A (en) * 1983-08-15 1985-07-09 Boris Tabakoff Composition and method for reducing blood acetaldehyde levels
JPS6116144A (en) 1984-06-29 1986-01-24 Fujitsu Ten Ltd Abnormal gear shift warning device
US5202354A (en) * 1986-02-18 1993-04-13 Takeda Chemical Industries, Ltd. Composition and method for reducing acetaldehyde toxicity
PH22818A (en) * 1986-02-18 1989-01-19 Takeda Chemical Industries Ltd Composition and method for reducing acetaldehyde toxicity
JPS62195323A (en) * 1986-02-24 1987-08-28 Eisai Co Ltd Gastric resident particle
CH674148A5 (en) * 1986-06-24 1990-05-15 Racz Istvan
EP0265061B1 (en) * 1986-09-18 1992-01-08 London School of Pharmacy Innovations Ltd Pharmaceutical formulation
HU201865B (en) 1989-04-28 1991-01-28 Pecsi Dohanygyar Tobacco-smoke filter of high efficiency
JPH0374327A (en) * 1989-08-16 1991-03-28 Ajinomoto Co Inc Excitometabolic agent for alcohol
JPH03136895A (en) 1989-10-23 1991-06-11 Fuji Electric Co Ltd Method for manufacturing optical information recording media
JPH0421635A (en) 1990-05-16 1992-01-24 Suntory Ltd Toxicity-suppressing agent of acetaldehyde and drink and food effective in suppression of toxicity of acetaldehyde
US5110423A (en) * 1990-05-25 1992-05-05 Technic Inc. Bath for electroplating bright tin or tin-lead alloys and method thereof
JP3013860B2 (en) 1991-03-22 2000-02-28 三菱瓦斯化学株式会社 Food preservative and method for preserving food using the same
FI93924C (en) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Procedure for the preparation of a drug that can be releasably controlled
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
JP3479986B2 (en) 1992-10-07 2003-12-15 大正製薬株式会社 Composition for preventing alcoholic liver injury
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
JPH09194361A (en) * 1996-01-19 1997-07-29 Wakunaga Pharmaceut Co Ltd Antitumor agent
AU6471696A (en) * 1996-07-22 1998-02-10 Kouki Bussan Yugenkaisha Novel adsorbent
US5829449A (en) 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
IN186245B (en) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US5922346A (en) 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
WO2000071145A1 (en) 1999-05-24 2000-11-30 Hee Jung Kim Composition for recovering from a hangover and for preventing brain cell damage
CA2386954C (en) * 1999-10-29 2011-12-13 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
FI121528B (en) 2000-10-30 2010-12-31 Biohit Oyj A pharmaceutical composition for reducing the risk of cancer by topically binding acetaldehyde in saliva, stomach or colon
ITPI20010014A1 (en) 2001-03-05 2002-09-05 Ivo Pera COMPOUND FOR FILTERS FOR CIGARETTES, OR OTHER SMOKING ITEMS, BASED ON ANTIOXIDANT SUBSTANCES AND THE FILTER SO OBTAINED
WO2002098405A1 (en) 2001-06-05 2002-12-12 Ajinomoto Co., Inc. Liver fibrosis inhibitors
JP2003055215A (en) 2001-06-05 2003-02-26 Ajinomoto Co Inc Hepatic fibrosis inhibitor
US6936283B2 (en) * 2003-07-25 2005-08-30 Langeland Bjoern T. Composition for stimulation of specific metallo-enzymes
KR20070034459A (en) 2004-02-17 2007-03-28 마르쿠스 그라프 폰 마투시카-그라이펜클라우 Alcohol Metabolism Control Composition

Also Published As

Publication number Publication date
EA009335B1 (en) 2007-12-28
CN1486177A (en) 2004-03-31
FI20002392L (en) 2002-05-01
WO2002036098A1 (en) 2002-05-10
ATE522203T1 (en) 2011-09-15
JP4691312B2 (en) 2011-06-01
FI20002392A0 (en) 2000-10-30
US9474733B2 (en) 2016-10-25
CN100467016C (en) 2009-03-11
JP2004512353A (en) 2004-04-22
ES2370811T3 (en) 2011-12-23
EP1339394B1 (en) 2011-08-31
US20050267042A1 (en) 2005-12-01
EP1339394A1 (en) 2003-09-03
FI121528B (en) 2010-12-31
EA200300532A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
AU2002212395A1 (en) Method and preparation for binding acetaldehyde in saliva, stomach and large intestine
NO331093B1 (en) Somatostatin analogues, method of preparation, pharmaceutical composition and use.
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
MXPA02003596A (en) Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation.
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
DZ3311A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0400636A3 (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
MXPA03004941A (en) Drug formulation having improved oral tolerability.
HUP0301688A3 (en) Amino alcohol derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402225A3 (en) Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
HUP0301817A3 (en) Kahalalide compounds, process for preparing thereof, pharmaceutical compositions comprising them and their use
HRP20030050B1 (en) Sustained-release preparations of quinolone antibiotics and method for preparation thereof
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
ZA200108001B (en) Processes for making pharmaceutical oral ECB formulations and compositions.
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0303270A3 (en) Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0300066A3 (en) Polypeptide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them
HUP0401906A3 (en) Novel cathepsin s inhibitors, process for their preparation and pharmaceutical compositions containing them